Antiepileptic drugs in the treatment of chronic headaches

Neurological Sciences

Volumn 24, Issue SUPPL. 2, 2003, Pages

  Agostoni, E ^a   Frigerio, R ^a   Santoro, P ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Antiepileptic drugs; Headache treatment

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; DIHYDROERGOTAMINE; GABAPENTIN; GLUTAMIC ACID; LAMOTRIGINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RIBOFLAVIN; SEROTONIN ANTAGONIST; TIAGABINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN;

4 AMINOBUTYRIC ACID METABOLISM; ANXIETY DISORDER; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; COMORBIDITY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; HEADACHE; HUMAN; MIGRAINE; MOOD DISORDER; NEUROPATHIC PAIN; NONHUMAN; SIDE EFFECT;

EID: 0038314354     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720300060     Document Type: Article

References (26)

1. Cutrer FM (2001) Antiepileptic drugs: how they work in headache. Headache 41[Suppl 1]:S3-10
2. Koehler OJ, Bruyn GW (1998) Migraine treatment in the Netherlands in the early twentieth century. Ned Tijdschr Geneeskd 142:2009-2013
3. Post RM, Silberstein SD (1994) Shared mechanisms in affective illness, epilepsy, and migraine. Neurology 44[Suppl 7]:S37-S47
4. Sørensen KV (1988) Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand 78:346-348
5. Leninger T, Wiemann M, Bingmann D, Hufnagel A, Bonnet U (2000) Different effects of GABAergic anticonvulsants on 4-aminopyridine-induced spontaneous GABAergic hyperpolarizations of hippocampal pyramidal cells - implication for their potency in migraine therapy. Cephalalgia 20:533-537
6. Pini LA, Lupo L (2001) Antiepileptic drugs in the preventive treatment of migraine headache: a brief review. J Headache Pain 2:13-19
7. Silberstein SD, Collins SD, for the Long-term Safety of Depakote in Headache Prophylaxis Study Group (1999) Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Headache 39:633-643
8. Freitag FG, Collins SD, Carlson HA, Goldstein J, Saper J, Silberstein S, Mathew N, Winner PK, Deaton R, Sommerville K for the Depakote ER Migraine Study Group (2002) A randomised trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 58:1652-1659
9. Schwartz TH, Karpitskiy VV, Sohn RS (2002) Intravenous valproate sodium in the treatment of daily headache. Headache 42:519-522
10. Freitag FG, Diamond S, Diamond ML, Urban GJ (2001) Divalproex in the long-term treatment of chronic daily headache. Headache 41:271-278
11. Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42:796-803
12. Wheeler SD, Carrazana EJ (1999) Topiramate-treated cluster headache. Neurology 53:234-236
13. Von Seggern RL, Pharm D, Mannix LK, Adelman U (2002) Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis. Headache 42:804-809
14. Potter DL, Hart DE, Calder CS, Storey JR (2000) A double-blind, randomized, placebo-controlled, parallel study to determine the efficacy of topiramate in the prophylactic treatment of migraine. Neurology 54[Suppl 3]:A15
15. Storey JR, Calder CS, Hart DE, Potter DL (2001) Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 41:968-975
16. El Amrani M, Massiou H, Bousser MG (2002) A negative trial of sodium valproate in cluster headache: methodological issues. Cephalalgia 22:205-208
17. Mathew NT, Rapaport A, Saper J et al (2001) Efficacy of gabapentin in migraine prophylaxis. Headche 41:119-128
18. Martinović Ž, Ristanović D (2001) Gabapentin in the treatment of migraine and epilepsy comorbid with mood and anxiety disorders. J Headache Pain 2:83-87
19. Rompel H, Bauermeister PW (1970) Aetiology of migraine and prevention with carbamazepine (Tegretol). S Afr Med J 44:75-80
20. Krusz JC (2000) Carbamazepine, controlled-release, is effective in reducing chronic headaches. Cephalalgia 20:422 (abstract)
21. Silberstein SD, Saper JR, Freitag FG (2001) Migraine: diagnosis and treatment. In: Wolff's headache and other pain. Oxford University, Oxford
22. Steiner TJ, Findley LJ, Yuen AW (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17(2):109-112
23. Lampl C, Buzath A, Klinger D, Neumann K (1999) Lamotrigine in the prophylactic treatment of migraine aura - a pilot study. Cephalalgia 19:58-63
24. D'Andrea G, Granella F, Ghiotto N, Nappi G (2001) Lamotrigine in the treatment of SUNCT syndrome. Neurology 57:1723-1725
25. Ghose K, Niven B, McLeod A et al (1996) Vigabatrin in the prophylaxis of drug resistant migraine: a double-blind crossover comparison with placebo. Cephalalgia 16:367
26. Freitag FG, Diamond S, Diamond ML (1999b) The prophylaxis of migraine with GABA-agonist, tiagabine: a clinical report. Headache 19:354 (abstract)